転移性肝がん(Metastatic Liver Cancer):治療薬開発パイプライン動向2014

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVE41017423)
◆英語タイトル:Metastatic Liver Cancer-Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVE41017423
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[転移性肝がん(Metastatic Liver Cancer):治療薬開発パイプライン動向2014]についてメールでお問い合わせはこちら
本調査レポートでは、世界における転移性肝がん(Metastatic Liver Cancer)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、転移性肝がん(Metastatic Liver Cancer)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・転移性肝がん(Metastatic Liver Cancer)の概要

・転移性肝がん(Metastatic Liver Cancer)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・転移性肝がん(Metastatic Liver Cancer)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・転移性肝がん(Metastatic Liver Cancer)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Metastatic Liver Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Metastatic Liver Cancer. This report provides information on the therapeutic development based on the Metastatic Liver Cancer dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Metastatic Liver Cancer
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Metastatic Liver Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Metastatic Liver Cancer and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
• Complete Pipeline intelligence and complete understanding over therapeutics development for Metastatic Liver Cancer
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Metastatic Liver Cancer pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions


*** レポート目次(コンテンツ)***

Table of Contents
• Metastatic Liver Cancer Overview
• Metastatic Liver Cancer Pipeline Therapeutics
• Metastatic Liver Cancer Therapeutics under Development by Companies
• Metastatic Liver Cancer Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Metastatic Liver Cancer Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Metastatic Liver Cancer Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Metastatic Liver Cancer Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Metastatic Liver Cancer – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Metastatic Liver Cancer – Discontinued Products
• Metastatic Liver Cancer – Dormant Products
• Companies Involved in Therapeutics Development for Metastatic Liver Cancer
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Metastatic Liver Cancer, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Metastatic Liver Cancer Assessment by Monotherapy Products
• Metastatic Liver Cancer Assessment by Combination Products
• Metastatic Liver Cancer Assessment by Route of Administration
• Metastatic Liver Cancer Assessment by Stage and Route of Administration
• Metastatic Liver Cancer Assessment by Molecule Type
• Metastatic Liver Cancer Assessment by Stage and Molecule Type
• Metastatic Liver Cancer Therapeutics – Discontinued Products
• Metastatic Liver Cancer Therapeutics – Dormant Products
• Products under Development by Companies, 2014


List of Figures
• Number of Products under Development for Metastatic Liver Cancer, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Metastatic Liver Cancer Assessment by Monotherapy Products
• Metastatic Liver Cancer Assessment by Combination Products
• Metastatic Liver Cancer Assessment by Route of Administration
• Metastatic Liver Cancer Assessment by Stage and Route of Administration
• Metastatic Liver Cancer Assessment by Molecule Type
• Metastatic Liver Cancer Assessment by Stage and Molecule Type


*** レポートのキーワード ***

転移性肝がん(Metastatic Liver Cancer)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • o-クロロスチレンの世界市場2019
    The Global O-Chlorostyrene (CAS 2039-87-4) Industry 2019 Market Research Report is a professional and in-depth study on the current state of the O-Chlorostyrene industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry c …
  • エアブローガンの世界市場
    Air Blow Gun Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, …
  • ボリビアにおけるマイニング(採鉱)市場の財政・制度動向(2014年上半期)
    The Ministry of Mining and Metallurgy, and the Bolivian Mining Corporation govern the mining industry in Bolivia. The Mining Code of 1977 (law No. 1997) governs and regulates mining activities for prospecting, exploration and exploitation of mineral resources in Bolivia.
  • 世界及び中国のベンジルトリエチルアンモニウムブロミド市場2016
    The 'Global and Chinese Benzyl triethyl ammonium bromide Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Benzyl triethyl ammonium bromide industry with a focus on the Chinese market. The report provides key statistics on the market …
  • ドイツのモバイル端末市場(~2015):ベンダー別販売状況
    Summary "Germany Mobile Handset Market to 2015: Mobile Handset Sales by Vendor" report provides a top-level overview and detailed insights into the operating environment for mobile operators. It is an essential tool for companies active across the telecom value chain in Germany and for new companies …
  • フランスのミカン類市場
    The report presents analysis of citrus fruit market in France. Scope Brief country profile includes general information and main economic indicators and specifies business environment in France Citrus Fruit market is analyzed by different parameters including domestic production and consumption. Fut …
  • Mitsubishi International Food Ingredients, Inc.(消費財分野):企業概要及びSWOT分析
    Synopsis Canadean's "Mitsubishi International Food Ingredients, Inc.: Ingredients - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business des …
  • 無水マレイン酸の日本市場2017-2021
    About The report brings together facts and figures about maleic anhydride market in Japan covering period of 2011-2021. Statistics, experts’ opinions and estimations are given. The report about maleic anhydride market in Japan covers: - manufacturers capacity, production volumes - company profiles - …
  • 高速剛性ドアの世界市場:販売動向2017
    Notes:Sales, means the sales volume of High Speed Rigid Doors Revenue, means the sales value of High Speed Rigid Doors This report studies sales (consumption) of High Speed Rigid Doors in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/cou …
  • エアロゲルの世界市場:シリカエアロゲル、カーボンエアロゲル、アルミナエアロゲル
    About Aerogel Aerogel is a highly porous and lightweight solid polymer material with 95-99 percent gas content. It has low density, high thermal resistivity, and high strength-to-weight ratio. The recyclable properties of aerogel make the material eco-friendly and sustainable. These unique propertie …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVE41017423 )"転移性肝がん(Metastatic Liver Cancer):治療薬開発パイプライン動向2014" (英文:Metastatic Liver Cancer-Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。